Core Insights - Wabtec Corporation (WAB) is set to report its second-quarter 2025 results on July 24, with a history of positive earnings surprises, having outperformed the Zacks Consensus Estimate in three of the last four quarters, averaging a beat of 5.86% [1][4]. Earnings Performance - The Zacks Consensus Estimate for WAB's Q2 2025 earnings is $2.18 per share, reflecting a 0.46% upward revision in the past 60 days and an 11.22% increase from the previous year's actual [4][5]. - WAB's Q1 2025 earnings per share were reported at $2.28, exceeding the Zacks Consensus Estimate of $2.01, marking a 20.6% year-over-year improvement [10]. Revenue Estimates - The Zacks Consensus Estimate for WAB's Q2 2025 revenues is $2.77 billion, indicating a 4.84% growth from the previous year [5]. - Q2 2025 Freight revenues are estimated at $2.01 billion, representing a 4.6% increase year-over-year, while Transit revenues are pegged at $763 million, indicating a 5.4% growth [6][7]. Influencing Factors - The anticipated earnings performance is supported by higher sales and operating margin expansion, although supply chain issues, economic and political uncertainties, and high costs may pressure margins and revenues [4][8]. - Wabtec's operations outside the U.S. expose it to foreign currency exchange rate fluctuations, which is a significant concern for its financials [8]. Earnings Prediction Model - The current model predicts a potential earnings beat for Wabtec, supported by a positive Earnings ESP of +0.50% and a Zacks Rank of 2 (Buy) [9].

Core Insights - WM is set to release its second-quarter 2025 results on July 28, with expectations of strong revenue growth and earnings performance [1][2]. Revenue Expectations - The Zacks Consensus Estimate for WM's revenues is $6.3 billion, reflecting a 17.4% increase from the same quarter last year [2]. - Revenue from the Collection segment is anticipated to be $4.7 billion, indicating a 13.7% year-over-year growth [3]. - Landfill revenues are estimated at $1.4 billion, suggesting a 9.5% increase compared to the previous year [3]. - The Transfer segment is projected to generate revenues of $692.5 million, representing a 12.1% rise year-over-year [3]. - The Recycling Processing and Sales segment is expected to bring in $535.8 million, marking a 12.8% increase from the prior year [4]. - WM Renewable Energy revenues are anticipated to reach $95.3 million, reflecting a significant 36.2% year-over-year growth [4]. - WM Healthcare Solutions is estimated to generate $278.2 million in revenues [4]. Earnings Performance - Adjusted EBITDA is projected at $1.9 billion, indicating a 16.3% growth from the same quarter last year [5]. - The consensus estimate for earnings per share (EPS) is $7.57, implying a 4.7% increase from the previous year [5]. - Strong margins and operational efficiency are expected to contribute positively to the bottom line [5]. Earnings Prediction - The model predicts an earnings beat for WM, supported by a positive Earnings ESP of +0.25% and a Zacks Rank of 3 (Hold) [6].

Core Viewpoint - NOV Inc. is expected to report second-quarter 2025 results on July 28, 2025, with earnings estimated at 30 cents per share and revenues at $2.1 billion, reflecting a year-over-year decline in both metrics [1][9]. Group 1: Recent Performance - In the last reported quarter, NOV missed the consensus earnings estimate, reporting adjusted earnings per share of 19 cents against an expected 25 cents, while revenues were $2.1 billion, a slight increase of 0.2% from the consensus [2]. - Over the trailing four quarters, NOV has beaten the Zacks Consensus Estimate twice and missed twice, with an average surprise of 12.6% [3]. Group 2: Revenue and Cost Expectations - The Zacks Consensus Estimate predicts a revenue decline for the second quarter, projecting revenues to decrease from $2.2 billion in the previous year to $2.1 billion [5][9]. - The Energy Products and Services segment is expected to generate revenues of $966 million, down from $1,050 million in the year-ago period, while the cost of goods sold is projected to rise to $1,674.8 million, indicating a 3% increase from the previous year [5][9]. Group 3: Segment Performance - Revenues from the Energy Equipment segment are anticipated to reach $1,216.6 million, an increase from $1,204 million in the year-ago period, with a strong backlog expected to rise by 13.1% year-over-year [6]. Group 4: Earnings Prediction Model - The Zacks model does not predict an earnings beat for NOV this quarter, as the Earnings ESP is -5.38%, and the company currently holds a Zacks Rank of 5 (Strong Sell) [7][8].

Core Viewpoint - Dow Inc. (DOW) is expected to report second-quarter 2025 results on July 24, with anticipated challenges from weak demand and pricing pressures despite productivity initiatives [1][6]. Revenue Estimates - The Zacks Consensus Estimate for DOW's revenues in the upcoming quarter is $10,445.6 million, indicating a year-over-year decline of 4.6% [4]. - Revenue estimates for specific segments include: - Packaging & Specialty Plastics: $5,197.9 million, a decline of 5.8% year over year [4]. - Industrial Intermediates & Infrastructure: $2,884.6 million, a decline of 2.3% year over year [4]. - Performance Materials & Coatings: $2,142.1 million, a decline of 4.5% year over year [7]. Factors Affecting Performance - DOW is facing headwinds from soft demand in Europe and China, with lower consumer spending and weak construction and manufacturing activities impacting performance [8][9]. - Inflationary pressures are affecting demand in consumer durables and construction, while automotive demand in Europe is also weak [9]. - The Performance Materials & Coatings segment is challenged by weak siloxane prices due to increased supply in Asia, particularly from China [10]. Cost-Saving Initiatives - DOW is implementing cost-saving measures aimed at reducing direct and labor costs, targeting $1 billion in savings to improve margins [11]. - The company expects to realize around $300 million in benefits from these actions in 2025, with full benefits anticipated by 2026 [11]. Earnings Prediction - The Earnings ESP for DOW is -53.04%, indicating a low likelihood of an earnings beat this quarter, with a consensus estimate of a loss of 8 cents [12][13]. - DOW currently holds a Zacks Rank of 5 (Strong Sell) [13].

Core Viewpoint - West Pharmaceutical Services (WST) is expected to report second-quarter 2025 results on July 24, with prior performance indicating a strong earnings beat of 18.85% in the last quarter and an average surprise of 7.81% over the past four quarters [1] Q2 Estimates - The company anticipates second-quarter revenues between $720 million and $730 million, reflecting a 3% to 4% organic sales growth, with adjusted diluted earnings per share (EPS) projected at $1.50 to $1.55 [2][8] - The Zacks Consensus Estimate for revenues stands at $726 million, indicating a 3.4% growth year-over-year, while the consensus for earnings is $1.51 per share, showing a decline of 0.7% year-over-year [3] Revenue and Segment Performance - Total revenue is estimated at $722.2 million, representing a 3.2% organic improvement year-over-year, with the Proprietary Products segment expected to generate $583.5 million (4.6% organic growth) and Contract-Manufactured Products projected at $138.7 million [4] - The Proprietary Products segment is experiencing solid demand, particularly for high-value products like GLP-1-related components, which constituted over 73% of segment revenues in the first quarter [6] Segmental Analysis - Biologics within Proprietary Products is expected to show mixed but stable performance, with the SmartDose platform gaining traction, although early-quarter challenges may temper growth [7] - In Contract Manufacturing, growth in GLP-1 auto-injectors is offsetting declines from continuous glucose monitoring (CGM) products, with the Dublin facility expected to enhance drug-handling capabilities over time [9] Operational Insights - The company reported a solid first-quarter performance in 2025, with revenues of $698 million and EPS of $1.45, demonstrating resilience amid industry-wide destocking challenges [5] - Despite macro pressures and inventory dynamics, operational efficiencies and disciplined cost management are expected to support gross margins, although a softer mix of lower-margin products may weigh on performance [10] Earnings Prediction - The model predicts an earnings beat for WST, supported by a positive Earnings ESP of +0.57% and a Zacks Rank of 2 (Buy) [11][12]

Core Insights - Take-Two Interactive is well-positioned to maintain its earnings-beat streak, particularly in the upcoming report, with a history of exceeding earnings estimates [1][5] - The company has an average surprise of 13.62% over the past two quarters, indicating strong performance [1] Earnings Performance - For the most recent quarter, Take-Two reported earnings of $1.08 per share, slightly below the expected $1.09, resulting in a surprise of 0.93% [2] - In the previous quarter, the company exceeded expectations by reporting $0.72 per share against a consensus estimate of $0.57, achieving a surprise of 26.32% [2] Earnings Estimates and Predictions - There has been a favorable change in earnings estimates for Take-Two, with a positive Earnings ESP of +13.93%, suggesting analysts are optimistic about the company's earnings prospects [5][8] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) indicates a high likelihood of another earnings beat [5][8] Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6] - The Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7] Upcoming Earnings Report - The next earnings report for Take-Two is expected to be released on August 7, 2025 [8]

Core Viewpoint - Fabrinet (FN) is positioned to potentially continue its earnings-beat streak in the upcoming report, supported by its strong historical performance in earnings surprises [1]. Company Performance - Fabrinet has a track record of exceeding earnings estimates, particularly in the last two quarters, with an average surprise of 3.00% [2]. - In the last reported quarter, Fabrinet achieved earnings of $2.52 per share, surpassing the Zacks Consensus Estimate of $2.47 per share, resulting in a surprise of 2.02% [3]. - For the previous quarter, the company was expected to report earnings of $2.51 per share but delivered $2.61 per share, yielding a surprise of 3.98% [3]. Earnings Estimates and Predictions - Estimates for Fabrinet have been trending upward, aided by its history of earnings surprises [6]. - The stock currently has a positive Zacks Earnings ESP of +1.14%, indicating increased analyst optimism regarding its near-term earnings potential [9]. - The combination of a positive Earnings ESP and a Zacks Rank of 2 (Buy) suggests a strong likelihood of another earnings beat [9]. Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise [7]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [8].

Core Insights - Halozyme Therapeutics (HALO) is positioned to potentially continue its earnings-beat streak in upcoming reports, having surpassed earnings estimates by an average of 12.73% in the last two quarters [1] Earnings Performance - For the most recent quarter, Halozyme was expected to report earnings of $1.11 per share but reported $0.95 per share, resulting in a surprise of 16.84%. In the previous quarter, the consensus estimate was $1.16 per share, while the actual earnings were $1.26 per share, leading to a surprise of 8.62% [2] Earnings Estimates and Predictions - Recent estimates for Halozyme have been increasing, with a positive Zacks Earnings ESP (Expected Surprise Prediction) indicating a strong likelihood of an earnings beat, especially when combined with a Zacks Rank of 3 (Hold) [5][8] - Stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have historically produced a positive surprise nearly 70% of the time, suggesting a high probability of beating consensus estimates [6] Earnings ESP Metric - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may be more accurate [7] - Halozyme currently has an Earnings ESP of +4.07%, indicating that analysts have recently become more optimistic about the company's earnings prospects [8] Importance of Earnings ESP - While many companies may beat consensus EPS estimates, this is not the only factor influencing stock price movements. Therefore, checking a company's Earnings ESP before quarterly releases is crucial for increasing the odds of success [9]

Core Insights - American Water Works (AWK) has consistently surpassed earnings estimates, making it a strong candidate for future investment opportunities [1][5] - The company reported earnings of $1.05 per share for the last quarter, exceeding the Zacks Consensus Estimate of $1.04 per share by 0.96% [2] - In the previous quarter, AWK's earnings were $1.22 per share against an expectation of $1.13, resulting in a surprise of 7.96% [2] Earnings Performance - Over the last two quarters, American Water Works has averaged a 4.46% earnings surprise [1] - The company's positive Earnings ESP (Expected Surprise Prediction) stands at +1.84%, indicating bullish sentiment among analysts regarding its near-term earnings potential [8] - The next earnings report for American Water Works is anticipated on July 30, 2025 [8] Zacks Rank and Predictive Metrics - American Water Works holds a Zacks Rank of 2 (Buy), which, when combined with its positive Earnings ESP, suggests a high likelihood of another earnings beat [8] - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise [6] - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7]

Core Viewpoint - CDW is positioned well to potentially beat earnings estimates in its upcoming quarterly report, supported by a strong history of exceeding expectations [1][2]. Earnings Performance - CDW has a solid track record of surpassing earnings estimates, with an average surprise of 8.07% over the last two quarters [2]. - In the last reported quarter, CDW achieved earnings of $2.15 per share, exceeding the Zacks Consensus Estimate of $1.96 per share by 9.69% [3]. - In the previous quarter, CDW's actual earnings were $2.48 per share, surpassing the expected $2.33 per share, resulting in a surprise of 6.44% [3]. Earnings Estimates and Predictions - Recent estimates for CDW have been trending upward, indicating positive sentiment among analysts [5]. - The Zacks Earnings ESP for CDW is currently +2.41%, suggesting increased bullishness regarding its near-term earnings potential [8]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) indicates a strong likelihood of another earnings beat [8]. Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7].